Expression of Wilms' tumor gene (WT1) is associated with survival in malignant pleural mesothelioma

S. Cedrés, M. A. Montero, E. Zamora, A. Martínez, P. Martínez, L. Fariñas, A. Navarro, D. Torrejon, A. Gabaldon, S. Ramon Y Cajal, E. Felip

Research output: Contribution to journalArticleResearchpeer-review

10 Citations (Scopus)

Abstract

Introduction: Calretinin and Wilms' tumor gene (WT1) are mesothelial markers routinely used to confirm the diagnosis of malignant pleural mesothelioma (MPM). We investigated the prognostic value of calretinin and WT1 expression in predicting survival in a series of patients diagnosed with MPM in our institution. Materials and methods: Fifty-two patients diagnosed of MPM were retrospectively reviewed. Calretinin and WT1 were stained for IHC analysis in formalin-fixed, paraffin-embedded sections and positivity was considered for tumors with >1 % of tumor cells stained. Survival data were calculated by the Kaplan-Meier method and Cox regression was used to evaluate the prognostic value of the variables. Results: Calretinin IHC expression was positive in 83.7 % of patients and WT1 in 78.1 %. A significant association of calretinin and WT1 expression with epithelial histology was detected (p = 0.030 and p = 0.010). We found a significant increase in OS in patients with epithelial subtype, PS1 and neutrophil-lymphocyte ratio (NLR) ≤5 (p < 0.05). In the IHC markers analysis, we found a significant increase in OS for patients with WT1 positive expression (16.4 vs. 2.3 m, p = 0.013), but not differences for calretinin expression (16.6 vs. 5.0 months, p = 0.37). In the multivariate analysis, epithelial histology and WT1 remained as significant prognostic factors for survival (p = 0.004 and p = 0.010, respectively). Conclusion: In our series of 52 MPM patients, epithelial histology, PS, NLR and WT1 expression are significant prognostic factors for survival. We concluded that WT1, but not calretinin, is a useful prognostic factor in MPM. The role of WT1 assessment is worth of prospective validation in future studies on MPM. © 2013 Federación de Sociedades Españolas de Oncología (FESEO).
Original languageEnglish
Pages (from-to)776-782
JournalClinical and Translational Oncology
Volume16
Issue number9
DOIs
Publication statusPublished - 1 Jan 2014

Keywords

  • Mesothelioma
  • Prognostic marker
  • WT1

Fingerprint Dive into the research topics of 'Expression of Wilms' tumor gene (WT1) is associated with survival in malignant pleural mesothelioma'. Together they form a unique fingerprint.

Cite this